Back to Forecasting
CEActive

Will any senior CE officer or director disclose an open-market purchase of CE common stock by December 31, 2026?

Resolves December 31, 2026(250d)
IG: 0.48

Current Prediction

20%
Likely No
Model Agreement94%
Predictions9 runs
Last UpdatedApril 25, 2026

Why This Question Matters

Insider activity is constructive-but-not-affirmative across two lenses (Insider Investigator, Fugazi Filter): no panic selling at depressed prices but no open-market buying at cycle lows either. A senior-officer open-market purchase by YE2026 would be a high-conviction governance affirmation that mgmt views the recovery thesis as live. This is asymmetrically informative — purchases are more reliable than sales for signal value. Absent purchase by YE2026 is the consensus-implied baseline; an actual purchase would shift GOVERNANCE_ALIGNMENT from MIXED toward ALIGNED.

GOVERNANCE_ALIGNMENT

Prediction Distribution

0%25%50%75%100%
opus
sonnet
haiku
Range: 18%25%Aggregate: 20%
Individual Predictions(9 runs)
opusRun 1
20%

No open-market purchases at cycle lows in 2024-2025 — the conservative read. Stock has rallied off lows ($40-65 range) reducing 'asymmetric upside' argument for new purchases at $65. CE historical pattern: rare insider buying outside post-IPO/post-distress. Counter: 'any senior officer or director' is broad criterion; 8-month window. Director purchases more common at cycle lows. Net ~20%.

No 2024-2025 purchasesRally reduces asymmetric upsideBroad criterion offsets
opusRun 2
22%

Q1 2026 earnings catalyst is upcoming. If earnings beat, mgmt has psychological window to 'validate the call' with purchases pre-narrative-confirmation. But mgmt comp is heavily stock-based — incremental buying not material. Director purchases more flexible. ~22%.

Q1 earnings catalystExisting exposureDirector flexibility
opusRun 3
18%

If mgmt high conviction, would have bought at $40-50 lows in 2024-2025. They didn't. Recent rally to $65 makes purchase less compelling psychologically. SEC trading windows constrain timing. ~18%.

No purchase at lowsRally reduces appealTrading window constraints
sonnetRun 1
25%

Sector base rate: ~25-35% historical probability for distressed cyclical company over 12-month window. CE-specific reduction: no purchase at recent lows is conservative read. Net ~25%.

Sector base rateCE-specific reduction12-month proxy
sonnetRun 2
22%

Begleiter equity-issuance question creates governance pressure for affirmative signal. Possible response: insider purchase as counter-narrative. But mgmt has shown reluctance. ~22%.

Governance pressureCounter-narrative motiveMgmt reluctance pattern
sonnetRun 3
20%

Stock pullback to $50 would reignite probability. At current $65, reduced. ~20%.

Stock level dependencyCurrent price reduces
haikuRun 1
20%

No purchases at lows. Rally reduces appeal. Broad criterion offsets. ~20%.

No prior purchasesRally contextBroad criterion
haikuRun 2
22%

Director flexibility + 8-month window + governance pressure. ~22%.

Director flexibilityLong windowGovernance pressure
haikuRun 3
20%

Sector base rate adjusted for CE-specific MIXED signal. ~20%.

Adjusted base rateMIXED signal

Resolution Criteria

Resolves YES if any current CE Section 16 officer (CEO, CFO, COO, GC, business unit presidents) or board director files a Form 4 between January 1, 2026 and December 31, 2026 disclosing an open-market purchase (transaction code 'P', not 'A' for award or 'M' for option exercise) of CE common stock with non-zero net cash outlay. Resolves NO if no such Form 4 is filed in the window.

Resolution Source

SEC EDGAR Form 4 filings for Celanese Corporation insider transactions

Source Trigger

Open-market insider purchase by any senior officer

insider-investigatorGOVERNANCE_ALIGNMENTHIGH
View CE Analysis

Full multi-lens equity analysis